BioMarin Pharmaceutical Inc. (BMRN) stock forecast — our track record
1 completed BMRN stock prediction — wins and misses, nothing deleted. Each forecast was published before the outcome was known.
How our BMRN forecasts have done
Lyra published 1 BMRN stock forecast, starting on December 19, 2025. It was a short term (0 to 3 months) prediction. The forecast was published before the outcome was known, then later closed and scored after its window ended on March 19, 2026. There were no medium term or long term calls to include here.
The target was not reached. There were no misses, because the call still rose partway toward its forecast rather than ending as a full miss. The average success score was 50%. The short term average score was also 50%, based on the 1 short term forecast. The stock's peak gain during the scoring window was 11%, compared with the predicted growth of 35%.
The best call and the worst call were the same forecast, because Lyra had only 1 closed BMRN call in this track record. On December 19, 2025, Lyra predicted 35% growth over the short term. The stock later rose as much as 11% during the window, but it did not reach the target. The verdict is simple: the call was partly right, but the target was not reached.
Written from the closed signals below; refreshed when new signals close.
Closed BMRN signals
| Closed | Timeframe | Predicted | Peak result | Outcome | Days to target | |
|---|---|---|---|---|---|---|
| March 19, 2026 |
Peak result is the highest point inside the signal’s measurement window — labelled as peak because it is not a realized return.
Share this receipt
The full public record for this symbol — wins and misses. Paste the link anywhere — it unfurls as the card above.
See what we’re calling today.
Every published signal is scored against what the stock actually did — the same way BMRN was. No deleted misses, no cherry-picking.